A meta-analysis of eye toxicity induced by tamoxifen in breast cancer patients
10.3969/j.issn.1005-1678.2017.07.108
- VernacularTitle:乳腺癌患者他莫昔芬治疗致眼毒性的荟萃分析
- Author:
Yuejuan ZHOU
;
Jing ZHAO
;
Yanfei MAO
;
Sha CHEN
- Keywords:
breast cancer;
tamoxifen;
ocular toxicity;
Meta-analysis
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):266-268
- CountryChina
- Language:Chinese
-
Abstract:
Objective Methodsof meta-analysis was used to investigate the clinical characteristics, related factors of ocular diseases caused by Tamoxifen.MethodsThe literature and key words in the literature search strategy were used to search the literatures related to the toxicity of tamoxifen in the treatment of breast cancer from 1980 to 2016.Refer to the literature, and extract the data information, use revman 5.1.7 statistical analysis.Results Tamoxifen was taken after t unilateral breast cancer resection by the patient,a sharp decline in visual acuity was found at the third month of taking Tamoxifen, and then the hospital diagnosed it was neuropapillitis.The analysis results show that the ocular toxicity of Tamoxifen was generally appeared after taking 1month to 100months.The most common eye diseases that result in Tamoxifen were macular edema and macular crystallization, although the cure rate was high, but if not treated ocular disease in time, blindness rate was high too.Ocular toxicity may be positive correlated with the cumulative dose of Tamoxifen and Tamoxifen concentration.The incidence rate may also positive correlated with age.Adverse reactions may be related to the metabolic rate, eye disease history and so on.Conclusion The clinical treatment of breast cancer treated with Tamoxifen, should pay attention to the ocular toxicity, replace drugs timely when there is any ADR that could not be tolerate.
